Latest Posts
About This Stock
More About This Stock
Read
Read
Shares Of Inotek Are Up 52% After Announcing End Of Phase 2 Meeting With FDA
Article By:
Terry Chrisomalis
Thursday, July 23, 2015 10:46 AM EDT
Inotek held an end of phase 2 meeting with FDA in order to set up a pivotal phase 3 trial that will put the drug Trabodenoson against a placebo compound for patients with Glaucoma.
In this article: ITEK
Morning Call For March 6, 2015
Article By:
Jim Van Meerten
Friday, March 6, 2015 8:47 AM EDT
March E-mini S&Ps (ESH15 -0.02%) this morning are down -0.06% ahead of the release of the U.S. Feb payrolls report, which may offer clues to the timing of U.S. interest rate increases, while European stocks are up +0.01%.